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Abstract 
 
Background: Preoperative nutritional counseling provides an opportunity to ameliorate patients' clinical 
condition and build-up adequate habits and perception of competence. Study aimed to evaluate: (a) the effect 
of INDIVIDUO on weight and metabolic control; (b) the impact of INDIVIDUO on psychosocial variables 
associated with successful weight-control.  
Methods: Two-arm randomized controlled single-site study, with six-month duration. Patients were 
recruited from an Obesity Treatment Unit waiting list. For the intervention group (IG), an operating 
procedure manual was used, nutritionists received training/supervision regarding INDIVIDUO's procedures. 
Control group (CG) received literacy-promoting intervention. Intention-to-treat and per-control analysis were 
used. Outcomes included weight, metabolic control variables (blood pressure, glycaemia, insulinemia, 
triglycerides, cholesterol), measures of eating and physical activity patterns, hedonic hunger, 
autonomous/controlled regulation, perceived competence for diet (PCS-diet) and quality of life. Primary 
coefficient.  
Results: 94 patients participated (IG:45; CG:49) and 60 completed the study (IG:29; CG:31). Intervention 
patients lost an excess 9.68% body weight (%EWL), versus 0.51% for CG. Adjusting for age and baseline 
BMI, allocation group remained an independent predictor of %EWL (B=8.43, 95%CI: 2.79-14.06). IG had a 
six-fold higher probability (OR:6.35, 95%CI: 1.28-31.56) of having adequate/controlled fasting glycaemia at 
final evaluation. PCS-diet at final evaluation was independently predicted by baseline PCS-diet (B=.31, 
95%CI: .06-.64), variation in autonomous regulation (B=.43, 95%CI: .15-.71) and allocation group (B=.26, 
95%CI: .04-1.36). 
Conclusions: Results on weight and metabolic control support INDIVIDUO as a valuable clinical tool for 
obesity surgery candidates counseling. Additionally, intervention associated with perceived competence for 
weight-control behaviors and autonomous regulation. 
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Introduction 
The management of obesity, as a chronic and prevalent disease, represents an escalating challenge for 
healthcare systems. As it demands relevant -care, insufficient compliance with 
prescribed behaviors is frequently pointed-out as the main motive for diminished success of treatment[1].  
Obesity-related social stigma  both a social justice issue and a 
public health challenge[2]. The excessive emphasis on corpulence 
expectancies to be focused on unreasonable weight reduction goals. For patients with severe obesity, the 
intensity and specificity of treatment needs to be in line with the magnitude of the disease, thus requiring 
differentiation and training for health professionals[3]. Obviously, when treating individuals suffering from 
severe obesity, it is difficult to diverge from weight loss as a primum movens for intervention. Nonetheless, 
the impact of the treatment on weight is only a piece, from a broader range of potential health gains, both at 
metabolic and health-related quality of life (HRQoL) levels.   
The short- and medium-term impacts on weight loss and overall health improvements support the arguments 
for obesity surgery as the most effective treatment for extreme cases of obesity (class three or class two plus 
one or more comorbidity). Best practice guidelines[4 6] recommend the decision to adopt surgical treatment 
be contingent on a comprehensive interdisciplinary assessment, with the core team including specialists 
experienced in obesity management and bariatric surgery (namely, physician, surgeon, anesthetist, 
psychologist and/or psychiatrist, nutritionist or dietitian, nurse practitioner and social worker).  
Nutritional counseling to obesity surgery candidates should aim at[4 6]: (a) contributing to the optimization 
of control of co-morbidities in order to reduce the risks associated with surgical procedures, (b) informing 
patients on the dietary changes that are required after surgery and (c) assessing patient motivation and 
willingness to adhere to post-operative behavior changes.  
Exposure to highly palatable foods (e.g. those rich in sugar and fat) may challenge a  long-term 
commitment to a healthy diet. Increased food intake may be driven by the activation of brain reward-circuits, 
which result from the experience of pleasure coming from the consumption of such foods (hedonic-driven 
food intake)[7,8]. Nonetheless, individuals who maintain their weight (after intentionally losing it) report 
strategies like ing  and ing  as valuable for their success[9]. These strategies 
are in line with the relevance of self-perceived competence, at the core of the broader concept of self-
determination as a key for adoption and maintenance of health-protecting behaviors[10 12].  
Given the inherent complexity of behavior change, particularly food-related, nutritional intervention with 
obesity surgery candidates lifestyle modification needed 
for successful (long-term) outcomes[5,6,13,14]. In broader terms, nutritional interventions should aim to 
contribute to patients' overall health improvements, benefiting those patients engaging in surgical treatment, 
as well as the ones who cannot or choose not to undergo surgical treatment.   
Since severe obesity is a complex clinical condition, the nutritional intervention design should address 
multiple eating behaviors, be sustained by suitable theoretical frameworks and be delivered together with 
evidence-based health practices, namely behavior-change strategies[3,15]. While patient-centered nutritional 
counseling prior to bariatric surgery is generally considered a pre-requisite for assessment of obesity surgery 
candidates, we did not find any well-defined and evidence-based guidelines for this counseling.  
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The therapeutic model INDIVIDUO (a Portuguese-derived acronym for lifestyle-focused nutritional 
) aims at fostering severely obese individuals with effective weight-
control behaviors, by combining evidence-based nutritional strategies with a patient-centered counselling 
style.  
The main goal of this study was to evaluate the effectiveness of INDIVIDUO as a therapeutic tool for obesity 
surgery candidates (i.e. in the context of pre-surgery obesity management). Specific goals are: (a) to evaluate 
the effect of INDIVIDUO in terms of weight control/reduction and metabolic improvement, namely, blood 
pressure (systolic and diastolic), fasting glycaemia, fasting insulin, hemoglobin A1c, fasting triglycerides, 
total cholesterol, LDL cholesterol and HDL cholesterol, and; (b) to evaluate the impact of INDIVIDUO in 
terms of eating patterns (reported number of meals) and light physical activity (in minutes), hedonic hunger, 
autonomous/controlled regulation for diet, perceived competence for diet (PCS-diet) and obesity-related 
quality of life. 
 
Materials and methods 
Study design 
INDIVIDUO was tested with a prospective, randomized controlled single-site study, with two arms: 
intervention and control groups. Data were collected at baseline and at a 6-month re-assessment prior to 
consultations in a hospital setting. Questionnaires were self-administered, with the exception of variables 
related to socio-demographics, personal family history of obesity, comorbidities and pharmacotherapy use, 
and dietary and physical activity patterns, which were obtained through face-to-face interviews by trained 
professionals (not involved in the intervention). 
 
Target population and sampling  
The study included all adult patients referenced to the Obesity Treatment Unit of a Portuguese hospital 
within the six-months-period before the beginning of the fieldwork. Following national norms for obesity 
surgery[6], only patients with obesity Class III or Class II (in this case, with at least one comorbidity) are 
considered eligible for obesity surgery. Pregnant patients and/or patients with diagnosed mental impairment 
were excluded. 
Eligible patients were stratified by sex and age groups (Younger: <40 years old; Middle-aged: 40-59 years; 
Older: > 59 years old), from which (subsample group) patients were randomly assigned to either the 
intervention or control group. The minimum sample size at the end of the trial was estimated to be of 25 
patients per group. This was calculated taking into account the usual productivity of the clinic over a 6-
month period[16] (timeframe of the study) and considering an average of 27% no-shows to a first 
appointment and an attrition rate of 36%. For minimizing inter-arm contamination, consultations with 
patients from the intervention group and from the control group were schedule in alternate weeks. From the 
census of patients (n=147), 53 did not participate (for reasons, see Figure 1). The total number of enrolled 
patients in the trial was 94 (45 in the intervention group and 49 in the control group). For gender and age 
distributions, no significant differences existed between participants and non-participants.  
  
----------------------------------------------INSERT FIGURE 1 HERE---------------------------------------------------- 
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Characteristics of the intervention to be tested 
Format and frequency of appointments 
To facilitate a more effective evaluation, usual appointment procedures of the outpatient clinic were 
reproduced. According to this, consultations were schedule every two months (i.e., four visits within the 
study timeframe), for the intervention group and twice for the control group (corresponding to baseline and 
final assessments).  
 
Counseling style and attitude  
INDIVIDUO centers itself around shared clinician-patient definition of goals and behavior change strategies, 
d behavioral prescription . Standing on the evidence that decision-making comes from an 
individual balance between the pros and cons of each behavior or goal[17,18], traditional directive 
prescription is replaced by the proposal of evidence-based strategies along with the invitation for patients to 
decide which strategies to adopt. Striving for a therapeutic setting which promotes shared-decisions, we have 
based our model on principles from the transtheoretical model of health behavior change[19], the self-
determination theory[20] and motivational interviewing[17]. Four main techniques define the interaction 
with patients: asking open questions; expressing empathy; signaling discrepancy, and; contributing to 
enhanced self-efficacy. As an example, nutritionists may use an adapted version of the usual twenty-four 
hour food recall (or usual 24-hour food recall), based on: a) open question, to identify established 
habits/routines; b) active listening, enabling discussion about perceptions and beliefs on eating behavior, and; 
c) empathy for perceived constraints, regarding food access and choices (clinical, economic, cultural, etc.). 
Tailored dietary advice would: (a) promote awareness of discrepancies between eating behaviors and related 
values, (b) value the -gain needs, (c) 
contribute to the perception of self-efficacy and (d) enhance change-talk[17,20]. 
 
Nutritional counseling content 
In order to fully address patients´ needs and therapy expectations, counseling ranges from the establishment 
of a full, personalized eating plan to a single strategy selection (see Figure 2 for strategies). INDIVIDUO 
uses three key principles for nutritional strategy selection and goal setting: a) basic nutritional needs 
satisfaction; b) therapeutic (weight and metabolic control) needs, and; 
routines and constraints (personal agenda and values, financial limitations, etc.).  
 
----------------------------------------------INSERT FIGURE 2 HERE---------------------------------------------------- 
 
Weight loss results from a negative energy balance and, consequently, is contingent on patients  engagement 
with a reduced-calorie diet[21]. Nonetheless, estimating individual energy needs through mathematical 
formulae is susceptible to both over- and under-estimation.[22 25]. This risk is even higher when dealing 
with individuals with severe obesity (e.g., due to wei
metabolic rate) and it may represent an obstacle to adherence to dietary prescription and its clinical 
outcomes[26]. As a starting point, a reference-value of 1800kcal/day was adopted, based on four premises: a) 
it was proposed in weight-loss guidelines and other randomized trials[27,28]; b) it represents a 
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light/moderate restriction to average expected individual needs[29,30]; c) it permits the inclusion of major 
food groups proposed by national guidelines[29]; d) it has been reported as the average energy consumption 
among successful weight losers[31].The characteristics of the baseline recommendations and the rational for 
the above-mentioned strategies were fully described elsewhere[32]. Since personalized guidance is the main 
strategy of INDIVIDUO, the referred baseline recommendations were used as a starting-point from which 
the nutritionist further developed an individualized eating plan for those in the intervention group. Energy 
and nutrient requirements were considered, as well as the selection of foods to provide them, taking into 
consideration  and expectancies.  
 
Interventionists training and quality control of the intervention 
Before starting the study, two clinical nutritionists received three days (24-hours) of training, covering 
IN -centered strategies, with the principal researchers (JC and OS). Taped 
role-plays and in depth discussion took place during this training. Additionally, these nutritionists assisted 12 
hours of consultations administered by JC (which strictly follows the INDIVIDUO principles). A standard 
operating procedure manual was created for the intervention. Across the trial, cases were discussed in weekly 
supervision meetings with JC and OS and other members of the research team. 
 
Control group intervention 
With regards to nutritional counseling, the control-group intervention was restricted to a literacy-promoting 
intervention, within the context of a formal appointment with a nutritionist (without training on the 
INDIVIDUO principles). This health-education intervention was based on the delivery and discussion of two 
documents: a leaflet with a list of weight-reduction strategies (similar to the ones proposed for the 
intervention group) and another leaflet describing a standard hypocaloric dietary plan, providing about 1800 
kcal/day divided across six meals (similar to baseline recommendations used for intervention group, without 
personalization of the meal plan). The main characteristics of the interaction with controls took into 
consideration the national guidelines[6], which establish that multidisciplinary evaluation prior to obesity 
surgery must include nutritional guidance about healthy dietary habits and their modifications after surgery. 
Accordingly, participants of the control group were also informed about the typical diet after obesity surgery.  
 
Hypothesis to be tested 
The present study using INDIVIDUO is targeted to individuals with severe obesity, candidates to bariatric 
surgery. It uses a low-intensity[27] individual intervention (i.e., less-than-monthly treatment sessions), over a 
six-month period. We hypothesized that intervention would translate into: a) higher weight loss/control; b) 
better metabolic control; c) better patients
health promoting behaviors, and; d) positive impact on health-related quality of life (HRQoL).    
 
Variables, main outcomes and statistical analysis 
Socio-demographic (gender, age, literacy and professional situation), as well as personal and family history 
of obesity were assessed. Additionally, patients were asked about comorbidities (diabetes, arterial 
hypertension, dyslipidemia, osteoarticular disease) and pharmacotherapy use. Weight and height were 
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measured by trained interviewers, using calibrated devices, according to official guidelines[33]. Body mass 
index (BMI) was computed as weight in kilograms divided by height in meters squared. Excessive weight 
was computed assuming desirable weight as the one corresponding to BMI=25. Systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) were measured according to national guidelines[34]. Blood 
samples, for fasting glycaemia, fasting insulin, glycated hemoglobin (HbA1c), fasting triglycerides, total 
cholesterol, LDL cholesterol (LDLc), and HDL cholesterol (HDLc) were collected after overnight fasting. 
Updated homeostatic model assessments (HOMA2), HOMA-%S and HOMA-%B were calculated and used 
as measures of beta cell function and insulin resistance[35]. Adequate glycemic control at final evaluation 
was assumed if [36]: a) fasting glycaemia was below 100mg/dL in both evaluations; b) baseline fasting 
glycaemia was between 100 and 125mg/dL and final (retest) fasting glycaemia was less than or equal to the 
baseline value or; c) baseline fasting glycaemia >125mg/dL and final (retest) fasting glycaemia was between 
70 and 130 mg/dL. The index TG/HDLc was computed and the cutoffs of 3.5 for men and 2.5 for women 
were used to identify individuals with insulin resistance and increased cardio-metabolic risk[37,38]. To get a 
ting patterns, an adapted version of a twenty-four hour 
recall was applied at baseline and final evaluation. Obesity-specific Physical Activity Recall (Ob-
PAR)[39,40] was used to assess time spent in sedentary behavior and in light physical activity[41]. Patients 
perceived competence for dieting was assessed using the Portuguese version of the Perceived Competence 
Scale (PCS)[42]. Self-regulation was evaluated using a modified version of the Treatment Self-Regulation 
Questionnaire (TSRQ)[10,11]. The applied version was composed of 12 items (coefficient alpha: .819); 
ranging from .785 to .815, when single items deleted), eight of them measuring autonomous regulation 
(coefficient alpha: .860) and four measuring controlled regulation (coefficient alpha: .732). Hedonic hunger 
(i.e., the drive to consume food in order to obtain pleasure) was assed using the Portuguese version of the 
questionnaire The Power of Food Scale (PFS)[8,43]. ORWELL-R was used to assess health-related quality 
of life[44]. 
Outcomes included weight, metabolic variables (blood pressure, glycaemia, insulinemia, triglycerides, and 
cholesterol), measures of eating and physical activity patterns, as well as hedonic hunger, 
autonomous/controlled regulation for diet, perceived competence for diet (PCS-diet) and quality of life. 
Primary outcomes were weight and metabolic control indicators. SPSS version 22.0 was used for statistical 
analyses. In line with international recommendations two distinct strategies of data analysis were done[45]: 
(1) intention-to-treat (ITT), as a primary analysis, and; (2) per-protocol, as a supportive analysis. The ITT 
analysis (treatment as assigned approach), considered all patients randomly allocated to both arms of the 
study at baseline with a last observation carried forward imputation for those who did not undergo the final 
evaluation. The per-protocol analysis (treatment as received approach), included only the subset of the ITT 
sample who completed both evaluations (baseline and final) without any major protocol violations. When 
describing differences between intervention and control group, results from both types of analysis are 
reported; for effect size assessment, only per-protocol approach results are reported in order to have an 
estimation of the impact of the treatment as received. The level of significance was always 95%. Normality 
of distributions was assessed through Shapiro-Wilk test, as well as per analysis of kurtosis and skewness 
(values in the -2 through +2 range). Variation between baseline and final assessments were used for 
comparison between the two arms of the trial, controlling for confounding variables (see Results section for 
8 
 
specific confounders for each variable). T-test or Mann-Whitney U test were used, depending on normality 
or non-normality, respectively. Linear and binary logistic regression (enter method) were used for assessing 
the effect size of the intervention (with odds ratio and 95% confidence intervals  95%CI). d 
coefficient was used for estimation of effect sizes. Spearman s correlation was used to study associations 
between clinical, behavioral and HRQoL variables.  
 
Ethical issues 
The study follows the Code of Ethics of the Declaration of Helsinki[46]. The study protocol was approved by 
the Ethics Commission of the Faculty of Medicine of Lisbon and by the Clinical Direction of the Hospital de 
Santa Maria. Patients voluntarily agreed to participate in the study and signed a detailed informed consent 
document before engaging in the study. No incentives were provided for participation. Patients were 
informed that their participation would not imply any benefit or prejudice regarding the usual treatment 
process. Having this in mind, dropout was assumed when patients specifically declined further follow-up or 
when they missed two consecutive appointments without any justification. As previously indicated, usual 
waiting list time for treatment start-up was unaffected, either for the intervention group or for the control 
group patients (who were enrolled in regular treatment at the expected timing, according to their position in 
the waiting list).  
 
Results 
Baseline characteristics and dropout rate 
In total, 94 patients participated in the trial: 45 for the intervention group and 49 for the control group. The 
baseline characteristics of the two groups were similar (Table 1).  
Overall, 60 patients completed the trial, 29 of which completed the intervention program and participated in 
the final assessment (dropout rate: 35.5%). From the 16 patients who did not finish the INDIVIDUO, 12 
were women (four men), with a mean age of 43.19 12.73 years old and a mean BMI of 42.41 5.80 kg/m2. 
Most of them (nine patients) dropped out after the first visit, four after the second and one after the third. For 
the control group, 31 individuals participated in the final assessment; among patients who dropped-out 
(38.0%) 14 were women (four men), with a mean age of 47.00 13.64 years old and a BMI of 41.83 5.78 
kg/m2.  No statistically significant differences were found between completers and non-completers for these 
variables (age and BMI).  
 
Most individuals reported that their obesity condition started as adults (61.3%, n=57), even though more than 
one fifth (22.6%, n=21) reported to suffer from obesity since birth. More than eighty percent (81.9%, n=77) 
reported to have someone also suffering from obesity in their close social network (family and/or friends) 
and more than three quarters (75.5%; n=71) reported a family history of obesity (i.e. presence of obesity in 
parents, grandparents and/or siblings). More than one-half (52.1%, n=49) of the individuals reported to have 
made ten or more previous attempts at weight loss. About forty percent of the individuals (42.6%; n=40;) 
were employed at the start of the study, with a similar percentage for the individuals completing (36.7%; 
n=22;) the six months assessment.    
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-------------------------------------------------INSERT TABLE 1 HERE-------------------------------------------------- 
 
Impact on weight and metabolic control 
The impact on weight was significantly more pronounced in the intervention group (the following variables 
are presented as averages for intervention vs. control groups): body weight (-4.21kg vs. -0.21kg, P< 0.01), 
BMI (-1.69 kg/m2 vs. -0.11kg/m2, P< 0.01); percentage weight loss  (-3.92% vs. -0.27%, P< 0.01) and 
percentage of excessive weight loss (%EWL: 9.68% vs. 0.51%, P< 0.01).  When adjusting for age and 
baseline body mass index, the allocation group remains an independent predictor of excessive weight loss 
(r2=.18; Adjusted r2=.14; =8.43, 95%CI: 2.79-14.06, P= 0.01).  
The decrease in body mass index had a positive association with improvement in fasting insulin (rs=0.443, 
P= 0.02) and HbA1c (rs =0.444, P= 0.02), but only for the intervention group. An overall positive impact 
from the intervention was observed for fasting glycaemia, insulin and glycated hemoglobin (Table 2). After 
excluding patients who reported intensification of diabetes-specific medication, significant impact from 
intervention on fasting glycaemia was detected (average variation: -4.43mg/dL for the intervention group vs. 
+0.04mg/dL for the control group; P= 0.03).  
 
-------------------------------------------------INSERT TABLE 2 HERE-------------------------------------------------- 
 
A logistic regression, adjusting for age, baseline fasting glycaemia and %EWL, modeled the impact of the 
intervention in achieving controlled fasting glycaemia at retest. The full model, containing all predictors, is 
statistically significant ( 2 (4, n=56)= 22.42, P< 0.01), explaining between 31.6 (Cox and Snell R square) and 
43.8% (Nagelkerke R squared) of the variance in glycemic control status (and able to correctly classify 
83.1% of cases). This arm of the study independently contributed to glycemic control (OR=6.46 (95%CI: 
1.28-31.56); P= 0.03): patients who received intervention were over 6 times more likely to have contolled 
glycemic levels at retest (Table 3). 
 
-------------------------------------------------INSERT TABLE 3 HERE-------------------------------------------------- 
 
Both at baseline and final evaluations (Figure 3), controls had a significantly higher HOMA2 index and 
lower insulin sensitivity (HOMA-%S). Concerning beta cell function (HOMA-%S), groups differed 
significantly at final evaluation. For the intervention group, a decrease in HOMA2 and a significant 
improvement in HOMA-%S were noticeable. Mean variations in insulin sensitivity were significantly 
different between groups (t(51)=-2.12; P= 0.04, effect size = 0,61). 
 
-------------------------------------------------INSERT FIGURE 3 HERE------------------------------------------------- 
 
A multiple linear regression was run to predict insulin sensitivity improvement, with baseline insulin 
sensitivity (HOMA-%S), percent weight variation and allocation group as the independent variables. All 
three variables were confirmed as predictors for insulin sensitivity improvement: baseline HOMA-%S ( = -
.57; 95%CI: -.84 to -.30, P< 0.001), %EWL ( =1.37, 95%CI: .65 to 2.09, P< 0.001) and intervention 
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( =18.96, 95%CI: 4.30 to 33.61, P= 0.01). Overall model fit: Z(3,48)=10,68, P<0.001, r2=.40; Adjusted r2 
=.36. 
At baseline, HOMA2 index was correlated with the TG/HDLc index (r= .307, P< 0.001). Using the same 
index (cutoffs: TG/HDLc  3.5 for men and TG/HDLc  2.5 for women), 38.4% of the initial sample could be 
classified as having increased cardiovascular risk. For the intervention group, final TG/HDLc correlated 
inversely with weight loss (r= -.376; P= 0.04).  
As shown in Table 2, lipid profile as well as blood pressure variations (between baseline and final 
observation) are not significantly different between groups. 
 
Impact on health-related quality of life, hedonic hunger, perceived competence and behavior change   
Although differences were not statistically significant, the intervention group showed a slightly higher 
average improvement in overall health-related quality of life (ORWELL-R total score: -11.04 vs. -6.58 for the 
control group), Body-environment experience subscale (-4.62 for intervention group vs. -3.38 for controls) 
and Illness perception & distress subscale (-5.66 for intervention group vs.-0.55 for controls). For the 
subscale Physical symptoms, opposite results were encountered with a higher improvement in the control 
group (-2.65) than in the intervention group (-0.76). For the control group, HRQoL improvement and %EWL 
were inversely correlated (r= -.38, P= 0.04). Percentage excessive weight loss was also negatively associated 
with test-retest decrease in hedonic hunger (r= -.37, P= 0.04). For the intervention group, reduction in 
hedonic hunger was positively correlated (r=.46, P= 0.01) with increments in perceived competence for diet 
(PCS-diet).  
Baseline PCS-diet was negatively associated with the presence of obesity in an close social 
network (partial correlation controlling for allocation group: r=-.24; P= 0.02) and positively associated with 
both autonomous (partial correlation controlling for allocation group: r=.34; P< 0.01) and controlled 
regulation (partial correlation controlling for allocation group: r=.27; P< 0.01). Nonetheless, at final 
evaluation, only increases in autonomous regulation were associated with increases in PCS-diet (partial 
correlation controlling for allocation group: r=.52; P< 0.001). In the linear model (Z(4,53)=5,01, p<.001, 
r2=.28; Adjusted r2 =.22), baseline PCS-diet (B=.31, 95%CI: .06 to .64, P= 0.02), variation in autonomous 
regulation (B=.43, 95%CI: .15 to .71, P< 0.001) and allocation group (B=.26, 95%CI: .04 to 1.36, P= 0.04) 
independently predicted final PCS-diet, whereas variation in controlled regulation were not associated with 
final PCS-diet. Considering the overall sample, enhancements in PCS-diet correlated positively with BMI 
reduction (r=.27, P=0.04) and with increases in reported number of meals (r=.32, P=0.01). Those patients 
who reported similar or increased number of meals had a significantly higher %EWL (6.77% vs. 1.29% for 
those patients reporting less meals at retest, compared to initial evaluation, P=0.03). Also noteworthy is the 
observation that overall variation in the number of meals associated positively with the reported time 
(number of minutes) of light physical activity at retest (r=.28, P=0.03).     
  
Discussion 
To our knowledge, this is the first study testing a low-intensity, patient-centered nutritional intervention, 
specifically tailored for individuals with severe obesity, namely obesity surgery candidates. Concerning the 
low-intensity characteristic, the frequency of contacts between patients and health-professionals may be (by 
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itself) a determinant for the impact of the diet therapy and it has been suggested that comprehensive lifestyle 
interventions, which provide less-than-monthly treatment sessions, do not consistently result in weight loss 
when compared with usual care[27]. In these terms, it is relevant to stress that INDIVIDUO replicates the 
usual frequency of nutrition appointments in the Obesity Treatment Unit, which, due to operational issues, 
averages one appointment every two months. This allowed us to evaluate its impact on weight-loss (as 
compared to one nutritional-counseling and literacy-promotion session) in a real-life setting, assuring the 
ecological validity of the effectiveness assessment.   
Despite the tendency of the intention-to-treat (ITT) analysis to dilute the treatment difference of interest[45], 
significant changes (test-retest differences) were observed for two primary outcomes (weight and fasting 
glycaemia) using both the ITT and the per-control analysis. Our  
compared to standard weight-control literacy promotion based counseling. Furthermore, since the main 
research goal for this study was to evaluate the effectiveness of a new intervention protocol (INDIVIDUO), 
the use of a per-protocol (non-intention to treat) analysis becomes adequate and its results more relevant.    
Concerning the relatively high dropout rate, it was similar to the  usual 
rate[16]. Therefore, being involved in this clinical trial was not a major contributor to patient dropout. 
Participants were mostly women, making it difficult to determine sex-specific responses. This 
overrepresentation of women replicates the usual gender distribution of the Unit and is comparable to other 
obesity surgery studies[47,48]. The six-month length of the study disallows inference about long-term impact 
of INDIVIDUO. Nonetheless, other studies adopted similar, or even shorter, intervention periods[48 50]. 
Additionally, the six-month duration of the intervention enabled individuals allocated to the control group to 
initiate regular treatment at the expected timing, according to their position in the waiting list. Therefore, 
they were not affected in terms of their normal treatment process.     
Thought not consensual, weight loss prior to obesity surgery may be required, based on clinical and 
reimbursement contingencies, such as the ones demanded by insurance companies. Still et al[48] showed that 
obesity surgery candidates who achieved a 5% to 10% decrease in excessive body weight before surgery lost 
weight more rapidly and had a higher probability of a shorter hospital stay postoperatively. Benotti et al[50] 
used a 6-month multidisciplinary program that encouraged candidates to lose 10% of excessive weight prior 
to surgery and concluded that preoperative weight loss is associated with fewer complications after gastric 
bypass surgery. Going back to the work from Still et al[48], beginning with an approximate 500-kcal deficit 
and a macronutrient composition of a prudent low-fat diet, patients were instructed to follow a 1000- to 
1500-kcal liquid diet if they had not reached their weight loss goal by month 4. In our study, for individuals 
in the intervention group, the average excessive weight loss was just below 10%, with nearly seventy percent 
losing 5% or more. These numbers are similar to the ones reported by Still et al[48]. We should highlight 
that weight loss goals were not pre-established for the intervention group (the eligibility criterion for the Unit 
does not include such a premise).       
Although using meal replacements (liquid and/or prepackaged meal replacements) may be a valid strategy in 
obesity management[51], we are convinced that one strong point in favor of INDIVIDUO is the fact that 
patients in the intervention group achieved clinically relevant weight loss using conventional foods. The 
effectiveness of the adopted patient-centered nutritional counseling strategy (ranging from the definition of a 
full, personalized eating plan to a single strategy selection) is reinforced by the significant impact on glucose 
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homeostasis. Our results are in line with the ones coming from the Finnish Diabetes Prevention Study[52], 
which used individually tailored dietary advice, regular foods and a frequency of contacts (between patients 
and nutritionists) similar to the ones chosen for INDIVIDUO. Our results for average decrease in fasting 
glycaemia for the treated individuals (-4.43mg/dl) are, in fact, quite similar to the ones reported by 
Tuomilehto and colleagues (-4mg/dl)[52]. Both, their results and ours, on fasting insulin failed to show 
statistically significant results. Nonetheless, they have shown significant differences after oral glucose 
challenge[52]. We have not performed a glucose tolerance test. Instead, we used HOMA2, HOMA-%S and 
HOMA-%B, as surrogate indexes for insulin sensitivity/resistance. Therefore, our data does not permit any 
specific conclusions on stimulated glucose and insulin systems (i.e. peripheral glucose uptake)[53]. 
Nonetheless, we found significant decreases in fasting glycaemia and a six-fold probability of having it 
controlled, significant decreases in insulin resistance and decreases in beta cell function (significantly lower 
final HOMA-%B) in the intervention group. These data are suggestive of an overall impact on glucose 
homeostasis.   
It was our expectation that the intervention would have a positive impact on lipid profile. The apparent 
absence of impact may be contingent on baseline average values (for triglycerides, total cholesterol, LDLc 
and HDLc), within normal ranges. Therefore, the non-significant variations may only mean that individuals 
maintained a desirable lipid profile. Within this hypothesis, it becomes noticeable that a very relevant 
proportion of those individuals receiving the intervention had adequate LDLc and HDLc.  
The proportion of patients achieving adequate blood pressure values was just above 25%, for both groups. 
Nonetheless, and without significant differences between groups, test-retest decreases for both SBP and DBP 
were observed. The decreases on SBP were less than the ones obtained with the low-sodium phase of the 
DASH diet (-8.9 mmHg, as compared to the high-sodium phase of the control diet), but quite similar to the 
ones detected on DBP (-4.5 mmHg, for the same comparison)[54].   
In their work, Benotti et al[50] acknowledge that preoperative weight loss alone may be a weak predictor of 
outcomes, and they propose other measures such as motivation, compliance, intellectual capability, social 
support, and economic status. According to these authors, such psychosocial variables can explain weight 
loss and moderate post-surgery results[50]. Our results also challenge the valuation of weight loss by itself. 
In fact, for the control group, weight loss was associated with decreases in HRQoL and increases in hedonic 
hunger. In the opposite direction, for the intervention group, the decrease in hedonic hunger was associated 
with increases in perceived confidence for diet.  
The baseline inverse association between PCS-diet and the presence of obesity in a social 
network can be supported by data from Christakis and Fowler[55], specifically the psychosocial shaping of 
an norms about overweightness and behaviors (e.g., food consumption patterns, physical activity 
engagement, etc.). Since a high proportion of our patients had close and regular contact with other persons 
with obesity, long-duration obesity and several failed attempts to lose weight, it becomes understandable that 
baseline PCS-diet associates not only with autonomous, but also controlled regulation. Within this context, 
Harrys and Hagger[56] noted that dieting tends to be a social behavior, with individuals pondering their own 
needs along with the opinions of others, when deciding to engage in dieting behavior. A strong point in favor 
of INDIVIDUO is that final PCS-diet is predicted by the intervention as well as by increments in 
autonomous regulation, without a significant predictive impact of controlled regulation. These results are 
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similar to those presented by other authors, who suggest that long-lasting behavior change becomes more 
probable if individuals endorse weight loss-related behavioral goals through feeling competent and 
autonomous about reaching them[57]. Our data also suggest that enhancements in PCS-diet translate into 
weight loss and a change in food-intake pattern (i.e. increase in reported number of meals). The first 
association can be read backwards, i.e., weight loss improves patient s perceived competence for diet. 
Nonetheless, since general and food-specific (e.g., palatable foods) underreporting is prevalent among 
subjects with obesity[58], the association between enhancements in PCS-diet and reported number of meals 
is more in favor of perceived competence being related to higher awareness and engagement with behavior 
change. This is reinforced by the positive association between reported eating episodes and amount of light 
physical activity and by the fact that maintaining or increasing meals were associated with larger amounts of 
excessive weight loss.   
Given its wide prevalence and comorbid conditions, obesity is a prominent problem for all health actors. In 
this paper, we describe and report findings on the effectiveness of INDIVIDUO. This intervention, directed 
to candidates for obesity surgery, integrates evidenced-based weight control strategies with a patient-
centered clinical approach. Without disregarding the clinical 
obesity-dedicated health professionals must challenge the paradigm of weight loss as their clinical 
. Better said, when approaching individuals with severe obesity, the challenge may not be to 
promote weight reduction by itself, but rather to help them achieve health gains that ultimately translate into 
long-term weight control. Considering the presented data, INDIVIDUO is a promising tool for pre-surgery 
nutritional counseling, deserving further research. In the challenging field of obesity management, next steps 
for INDIVIDUO would be to clarify its impact on medium/long-term surgery outcomes, specifically, on 
patients  self-care competencies regarding lifestyle and, ultimately, weight, comorbidities and overall 
sustained gains in obesity-related quality of life.       
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Figure 1: List of objectives and strategies for hin 
INDIVIDUO.  
  
 
Replace equivalent proportions of energy-dense and nutritionally poor foods by 
nutritionally rich ones 
Diminish sugar intake by avoiding added sugars and sugar-sweetened beverages 
Control fat intake by avoiding high-fat foods and fat addition (as spread, 
condiment and dressing) 
Increase water-rich vegetable proportions in meals: soups, garnish and recipe 
(novel) ingredients 
Adopt Mediterranean cooking methods and ingredients with a twist: selecting 
low-fat ingredients and trim fat, controlling added fat in sautéed preparations, and 
using herbs and spices to reduce salt addition 
Decrease 
energy 
density of 
diet 
Engage in a stable day-to-day meal pattern of, at least, three meals 
Adopt breakfast, lunch and dinner as anchor meals 
Consider intermediary eating episodes (e.g., pre-planned snacks) if useful for 
appetite control and for optimizing food selection 
Increase awareness on food selection and portion control, when meal patterns are 
unstable or not possible 
Adopt 
regular 
eating 
patterns 
Diminish the size of each forkful, put down tableware between forkfuls or go 
along with a slow-eating commensal 
Decrease 
eating rate  
Decrease time spend with sedentary behaviors (screen time, seated activities) 
Increase non-structured physical activities, such as walking to workplace/school, 
using stairs (instead of elevators), engage in housekeeping and gardening activities, 
dancing, etc. 
Engage in advised/accompanied structured physical exercise, whenever available 
and if suitable for the patient 
Engage 
with 
regular 
physical 
activity 
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Figure 2. Allocation algorithm 
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Figure 3: Homeostatic model assessment (HOMA2), insulin sensitivity (HOMA-%S) and beta cell 
function (HOMA-%B) variation, by group (per-protocol, corrected for medication intensification and for 
model specifications: 26 patients from intervention group and 24 from the control group were used in this 
analysis) 
 
 
*p<0.05: CI:  95% confidence interval 
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Table 1.  
Baseline characteristics of participants (intervention and control groups)  
Variable 
Intervention group 
(n= 45) 
Control group 
(n= 49) P
  
Female: n (%) 37 (82.2) 39 (79.6) ns 
Age 
Younger-ages (<40 years): n (%)  14 (31.0) 20 (40.8) 
ns Middle-aged (40-59 years): n (%)  23 (51.0) 23 (46.9) 
Older-ages ( 60 years): n (%) 8 (17.8) 6 (12.2) 
mean ± standard deviation 46.31 ± 13.65 43.53 ± 13.92 ns 
Body-mass Index  42.81 ± 4.96 43.45 ± 7.04 ns 
Comorbidity 
(self-report)  
Any type: n (%) 33 (73.3) 35 (71.4) ns 
Diabetes: n (%) 9 (20.0) 14 (28.6) ns 
Dyslipidemia: n (%) 20 (44.4) 14 (28.6) ns 
Hypertension: n (%) 26 (57.8) 24 (49.0) ns. 
Osteoarticular disease: n (%) 6 (13.3) 8 (16.3) ns 
Medication 
intake  
(self-report) 
Diabetes: n (%) 9 (20.5) 11 (22.4) ns 
Dyslipidemia: n (%) 12 (27.3) 11 (22.4) ns 
Hypertension: n (%) 17 (38.6) 21 (42.9) ns 
Glucose 
homeostasis 
Fasting glycaemia (mg/dl) 96.44 ± 14.36 104.05 ± 16.90 ns 
Hemoglobin A1c (%) 5.82 ± 0.69 5.84 ± 0.67 ns 
Fasting insulin (mU/L) 21.21 ± 14.60 24.13 ± 11.52 ns 
Blood pressure 
Systolic (mmHg) 142.78 ± 19.29 139.84 ± 16.15 ns 
Diastolic (mmHg) 84.64 ± 11.11 85.82 ± 10.44 ns 
Lipid profile 
Fasting triglycerides (mg/dl) 118.67 ± 56.48 126.14 ± 50.08 ns 
Total cholesterol (mg/dl) 188,00 ± 40.42 188.21 ± 33.13 ns 
LDL cholesterol (mg/dl) 111.70 ± 34.38 113.32 ± 24.30 ns 
HDL cholesterol (mg/dl) 52.67 ± 13.98 50.0 ± 11.47 ns 
Health-related 
quality of life 
(ORWELL-R) 
Overall score 240.29 ± 80.17 234.96 ± 101.15 ns 
Body-environment experience 126.89 ± 45.12 128.88 ± 53.91 ns 
Illness perception & distress 93.02 ± 34.99 82.98 ± 37.74 ns 
Physical symptoms 20.38 ± 14.51 23.10 ± 16.65 ns 
P-values are for the intervention-control inter-group comparisons; n.s. for non-significant differences, at =.05; Body-
mass index: weight in kilograms divided by the square of the height in meters 
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Table 2.  
Variation (by group) in weight, glucose homeostasis, blood pressure and lipid profile*  
 
 
Intention-to-treat analysis  
(with last observation carried forward)  
Per-protocol analysis 
(patients who completed both evaluations) 
 
Intervention 
group 
(n= 45) 
Control 
group 
(n= 49) 
P-value  
Intervention 
group 
(n= 29) 
Control 
group 
(n= 31) 
P-value  
       
BMI -1.09 (1.53) -0.07 (1.45) .001 -1.69 (1.62) -0.11 (1.83) .001 
Weight lost (%) -2.53 (3.52) -0.17 (3.33) .001 -3.92 (3.72) -0.27 (4.21) .001 
Excessive weight lost (%) -6.24 (8.80) -0.32 (9.07) .001 -9.68 (9.34) -0.51 (11.47) .001 
>5% excessive weight lost (%) 24,4 6,1 
.008 
37,9 9,7 
.002 
>10% excessive weight lost (%) 20,0 10,2 31,0 16,1 
        
Fasting glycaemia (mg/dl)*  -1.91 (6. 72) 1.24 (8.65) .019 -3.03 (8.33) 2.17 (11.46) .030 
Hemoglobin A1c (%)* -0.13 (0.33) -0.05 (0.18) n.s. -0.20 (0.39) -0.09 (0.23) n.s. 
Fasting insulin (mU/L) * -1.71 (8.27) 0.05 (7.02) n.s. -2.73 (10.37) 0.09 (9.37) n.s. 
       
Fasting triglycerides (mg/dl) * 1.91 (30.72) 1.87 (39.90) n.s. 3.04 (39.00) 3.04 (51.11) n.s. 
Total cholesterol (mg/dl) * 0.37 (20.23) 7.55 (23.17) n.s. 0.59 (25.71) 1.21 (29.68) n.s. 
LDL cholesterol (mg/dl) * 1.63 (20.41) 2.68 (19.78) n.s. 2.59 (25.89) 4.35 (25.21) n.s. 
HDL cholesterol (mg/dl) * 1.67 (6.15) 2.30 (4.81) n.s. 2.67 (7.64) 3.72 (5.71) n.s. 
       
Systolic blood pressure (mmHg) * -2.07 (10.67) -1.89 (8.92) n.s. -3.25 (13.32) -3.21 (11.26) n.s. 
Diastolic blood pressure (mmHg) * -2.68 (9.18) -3.13 (7.58) n.s. -4.21 (11.29) -5.07 (9.18) n.s. 
*Variation between baseline and final evaluation: presented as mean (standard deviation) and corrected for medication intensification 
(patients extracted from analysis: one patient from the intervention group and two from the control group, for antidiabetics; one from 
each group, for antihypertensives; one from intervention group, for antidyslipidemics); p-values for between-groups comparisons 
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Table 3. 
Logistic regression examining the differences between having or not controlled glycaemia, by group. 
Predictors 
 
 
SD 
Wald 
Df P 
Odds 
Ratio 
95.0% C.I. for Odds 
Ratio 
Lower Upper 
Group 1.85 0.82 5.11 1 .02 6.35  1.28 31.56 
Age -0.07 0.03 4.31 1 .04 0.93 0.87 1.00 
Baseline glycemia -0.03 0.02 2.81 1 .09 0.97 0.93 1.01 
%EWL  0.02 0.04 0.35 1 .55 1.02 0.95 1.10 
Constant 6.56 2.07 10.01 1 .00 701.83   
 %EWL: Percentage of excessive weight loss; per-protocol analysis. 
 
